Dr. Paul Janssen was the founder of Janssen Pharmaceutica and the developer of over 80 pharmaceutical compounds that proved useful in human, botanical, and veterinary medicine. He and his coworkers synthesized the fentanyl family of drugs, many other potent analgesics, droperidol, etomidate, and numerous other important medicines that were extremely useful in psychiatry, parasitology, gastroenterology, cardiology, virology, and immunology. Anesthesiology and medicine as a whole have benefited a great deal from his resourcefulness, creativity, and entrepreneurial spirit.
IMPLICATIONS: Few in the field of anesthesiology appreciate the sheer magnitude of Dr. Janssen’s numerous contributions to various fields in human, botanical, and veterinary medicine. From the invention and development of over 80 pharmaceutical compounds to his monumental merger of Janssen Pharmacuetica with Johnson and Johnson, Dr. Paul Janssen truly embodies what it means to be a productive scientist and an entrepreneur extraordinaire.
From the *Department of Anesthesiology, University of Utah, Salt Lake City, Utah; and †Department of Anesthesiology and Critical Care, Universitätsklinikum Münster, Albert-Schweitzer-Straβe, Münster, Germany.
Accepted for publication October 3, 2007.
Conflict of interest: None of the authors of this manuscript believe they have a conflict of interest with Janssen Pharmaceutica or the J&J Corporation.
Address correspondence and reprint requests to Theodore H. Stanley, MD, Department of Anesthesiology, University of Utah School of Medicine, 30 North 1900 East, 3C444 SOM, Salt Lake City, UT 84132. Address e-mail to email@example.com.